Iceland<\/a>\u00a0on Oct. 8 halted the use of the\u00a0Moderna<\/a>\u00a0vaccine against the\u00a0CCP virus<\/a>\u00a0due to reports from Nordic countries of\u00a0\u201cincreased incidence\u201d of inflammation of heart muscle and tissues triggered by the injection.<\/strong><\/p>\n Sweden, Finland, Denmark, and Norway have already limited the use of the\u00a0Moderna vaccine<\/a>\u00a0over the same concerns.\u00a0Iceland went further than its neighbors and stopped using the vaccine entirely.<\/em><\/u><\/strong><\/p>\n \u201cIn recent days, there has been data from the Nordic countries on the\u00a0increased incidence of myocarditis and pericarditis after vaccination with Moderna vaccine\u00a0<\/strong>in addition to vaccination with Pfizer\/BioNTech (Comirnaty),\u201d\u00a0an\u00a0announcement<\/a>\u00a0from Iceland\u2019s Directorate of Health stated.<\/p>\n \u201cAs there is a sufficient supply of Pfizer vaccine in Iceland for both the pre-vaccine activation vaccines and the primary vaccinations of those who have not yet been vaccinated,\u00a0the epidemiologist has decided not to use the Moderna vaccine in Iceland,\u00a0<\/strong>while providing further information on the safety of the Moderna vaccine.\u201d<\/p><\/blockquote>\n Sweden limited the use<\/strong>\u00a0of the Moderna shot on Oct. 6 to those born before 1991. The Swedish health agency\u00a0said<\/a>\u00a0at the time that new data from Swedish and other Nordic sources \u201cindicate that the connection is especially clear\u201d between Moderna\u2019s vaccine and side effects \u201cespecially after the second dose.\u201d<\/p>\n \u201cBoth myocarditis and pericarditis often go away on their own, without causing any lasting problems, but suspicious symptoms should be assessed by a doctor at \u2026 a health center or emergency room,\u201d the agency stated, noting that \u201cmedical treatment and monitoring in hospital may be needed in established cases.\u201d<\/p><\/blockquote>\n Norway and Denmark have recommended the Pfizer vaccine for children aged 12-17.\u00a0In Iceland, only the Pfizer vaccine has been recommended for the 12-17 age group.<\/strong><\/p>\n Finland on Oct. 7\u00a0discontinued<\/a>\u00a0the use of the Moderna shot for men under the age of 30.<\/strong><\/p>\n That decision came one day after Sweden and Denmark\u00a0halted<\/a>\u00a0the use of the vaccine for the younger age groups.<\/p>\n Iceland had been using the Moderna vaccine almost exclusively as a booster shot for those who received the Johnson&Johnson vaccine,\u00a0<\/strong>according to the Health Directorate. The Nordic nation had also been using the Moderna vaccine as a booster for two-dose vaccinations of the elderly and immunocompromised.<\/p>\n According to the World Health Organization, more than\u00a075 percent<\/a>\u00a0of Iceland\u2019s population has been fully vaccinated against the CCP (Chinese Communist Party) virus, commonly known as the novel coronavirus, which causes COVID-19.<\/p>\n![\"\"](\"https:\/\/assets.zerohedge.com\/s3fs-public\/styles\/inline_image_mobile\/public\/inline-images\/moderna-700x420.jpg?itok=kbewTjJ9\")
<\/picture><\/a><\/p>\n